These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 10462828)
1. Management of stage pTxN+ adenocarcinoma of the prostate: influence of radical prostatectomy on progression-free interval. Wu TT; Lu CM; Lee YH; Hwang JK Zhonghua Yi Xue Za Zhi (Taipei); 1999 Aug; 62(8):514-20. PubMed ID: 10462828 [TBL] [Abstract][Full Text] [Related]
2. Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy. Cadeddu JA; Partin AW; Epstein JI; Walsh PC Urology; 1997 Aug; 50(2):251-5. PubMed ID: 9255297 [TBL] [Abstract][Full Text] [Related]
3. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer. Bhatta-Dhar N; Reuther AM; Zippe C; Klein EA Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451 [TBL] [Abstract][Full Text] [Related]
4. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy. Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480 [TBL] [Abstract][Full Text] [Related]
5. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719 [TBL] [Abstract][Full Text] [Related]
6. Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Schumacher MC; Burkhard FC; Thalmann GN; Fleischmann A; Studer UE Eur Urol; 2008 Aug; 54(2):344-52. PubMed ID: 18511183 [TBL] [Abstract][Full Text] [Related]
8. Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison. Ghavamian R; Bergstralh EJ; Blute ML; Slezak J; Zincke H J Urol; 1999 Apr; 161(4):1223-7; discussion 1227-8. PubMed ID: 10081874 [TBL] [Abstract][Full Text] [Related]
9. Limited pelvic lymph node dissection does not improve biochemical relapse-free survival at 10 years after radical prostatectomy in patients with low-risk prostate cancer. Weight CJ; Reuther AM; Gunn PW; Zippe CR; Dhar NB; Klein EA Urology; 2008 Jan; 71(1):141-5. PubMed ID: 18242383 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of open radical retropubic prostatectomy for clinically localized prostate cancer in the prostate-specific antigen era. Dorin RP; Daneshmand S; Lassoff MA; Cai J; Skinner DG; Lieskovsky G Urology; 2012 Mar; 79(3):626-31. PubMed ID: 22245303 [TBL] [Abstract][Full Text] [Related]
11. Open pelvic lymph node dissection for prostate cancer: a reassessment. Campbell SC; Klein EA; Levin HS; Piedmonte MR Urology; 1995 Sep; 46(3):352-5. PubMed ID: 7544933 [TBL] [Abstract][Full Text] [Related]
12. Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy. Rogers CG; Khan MA; Craig Miller M; Veltri RW; Partin AW Cancer; 2004 Dec; 101(11):2549-56. PubMed ID: 15470681 [TBL] [Abstract][Full Text] [Related]
13. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome. De La Roca RL; Da Cunha IW; Bezerra SM; Da Fonseca FP Int Braz J Urol; 2014; 40(3):306-15. PubMed ID: 25010296 [TBL] [Abstract][Full Text] [Related]
14. Early surgical results with intent to treat by radical retropubic prostatectomy for clinically localized prostate cancer. Abbas F; Siddiqui K; Biyabani SR; Hasan SH; Talati J J Pak Med Assoc; 2002 May; 52(5):200-5. PubMed ID: 12174491 [TBL] [Abstract][Full Text] [Related]
15. Surgical management of lymph-node-positive prostate cancer: improves symptomatic control. Wiegand LR; Hernandez M; Pisters LL; Spiess PE BJU Int; 2011 Apr; 107(8):1238-42. PubMed ID: 20880197 [TBL] [Abstract][Full Text] [Related]
16. Long-term outcome in patients with pTxN+ adenocarcinoma of prostate treated with radical prostatectomy and early androgen ablation. Seay TM; Blute ML; Zincke H J Urol; 1998 Feb; 159(2):357-64. PubMed ID: 9649239 [TBL] [Abstract][Full Text] [Related]
17. Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy. Gonzalez CM; Roehl KA; Antenor JV; Blunt LW; Han M; Catalona WJ Urology; 2004 Oct; 64(4):723-8. PubMed ID: 15491709 [TBL] [Abstract][Full Text] [Related]
18. Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era. Dorin RP; Lieskovsky G; Fairey AS; Cai J; Daneshmand S Urol Oncol; 2013 Nov; 31(8):1441-7. PubMed ID: 22516714 [TBL] [Abstract][Full Text] [Related]
19. Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate. Oefelein MG; Smith ND; Grayhack JT; Schaeffer AJ; McVary KT J Urol; 1997 Oct; 158(4):1460-5. PubMed ID: 9302143 [TBL] [Abstract][Full Text] [Related]
20. The impact of robotic surgery on pelvic lymph node dissection during radical prostatectomy for localized prostate cancer: the Brown University early robotic experience. Yates J; Haleblian G; Stein B; Miller B; Renzulli J; Pareek G Can J Urol; 2009 Oct; 16(5):4842-6. PubMed ID: 19796462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]